Use of migraine prophylaxis medications such as candesartan can reduce need for triptans, a Scandinavian study shows. Presented at the European Academy of Neurology (EAN) 2019 Congress in Oslo, the analysis was based on data from 277,191 patients with migraine who had a prescription record of using triptans. Researchers examined the impact of potential prophylaxis ...
Already a member?
Enter your email to keep reading.